Viking Therapeutics, Inc.
2019 Q4 - 2025 Q4 (22 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 1/27/2026 | 1,294 | 0.0% | 36,777 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 941 | 0.0% | 35,809 | 9/30/2025 |
| 2025 Q2 | 8/7/2025 | 862 | 0.0% | 32,545 | 6/30/2025 |
| 2025 Q1 | 5/7/2025 | 735 | 0.0% | 30,446 | 3/31/2025 |
| 2024 Q4 | 2/7/2025 | 1,080 | 0.0% | 26,835 | 12/31/2024 |
| 2024 Q3 | 11/14/2024 | 1,445 | 0.0% | 22,823 | 9/30/2024 |
| 2024 Q2 | 7/29/2024 | 1,176 | 0.0% | 22,177 | 6/30/2024 |
| 2024 Q1 | 4/25/2024 | 1,511 | 0.0% | 18,422 | 3/31/2024 |
| 2023 Q4 | 1/30/2024 | 378 | 0.0% | 20,337 | 12/31/2023 |
| 2023 Q3 | 10/25/2023 | 184 | 0.0% | 16,639 | 9/30/2023 |
| 2023 Q2 | 8/7/2023 | 203 | 0.0% | 12,503 | 6/30/2023 |
| 2023 Q1 | 5/8/2023 | 151 | 0.0% | 9,083 | 3/31/2023 |
| 2022 Q1 | 4/21/2022 | 61 | 0.0% | 20,294 | 3/31/2022 |
| 2021 Q4 | 2/1/2022 | 93 | 0.0% | 20,294 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 51 | 0.0% | 8,149 | 9/30/2021 |
| 2021 Q2 | 7/30/2021 | 49 | 0.0% | 8,149 | 6/30/2021 |
| 2021 Q1 | 5/3/2021 | 52 | 0.0% | 8,149 | 3/31/2021 |
| 2020 Q4 | 1/28/2021 | 46 | 0.0% | 8,149 | 12/31/2020 |
| 2020 Q3 | 11/6/2020 | 47 | 0.0% | 8,149 | 9/30/2020 |
| 2020 Q2 | 7/28/2020 | 59 | 0.0% | 8,149 | 6/30/2020 |
| 2020 Q1 | 5/6/2020 | 18 | 0.0% | 3,939 | 3/31/2020 |
| 2019 Q4 | 1/21/2020 | 32 | 0.0% | 3,939 | 12/31/2019 |